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Tumor oxygenation is a critical issue for enhancing radiotherapy (RT) effectiveness. 
Alternating RT with hyperthermia improves tumor radiosensitivity by inducing a massive 
vasodilation of the neoangiogenic vasculature provided the whole tumor is properly heated. 
The aim of this work was to develop superparamagnetic oxygen-loaded nanobubbles 
(MOLNBs) as innovative theranostic hyperthermic agents to potentiate tumor oxygenation 
by direct intracellular oxygen administration. Magnetic oxygen-loaded nanobubbles were 
obtained by functionalizing dextran-shelled and perfluoropentane-cored nanobubbles with 
superparamagnetic iron oxide nanoparticles. Magnetic oxygen-loaded nanobubbles with 
sizes of about 380 nm were manufactured, and they were able to store oxygen and in vitro 
release it with prolonged kinetics. In vitro investigation showed that MOLNBs can increase 
tissue temperature when exposed to radiofrequency magnetic fields. Moreover, they are easily 
internalized by tumor cells, herein releasing oxygen with a sustained kinetics. In conclusion, 
MOLNBs can be considered a multimodal theranostic platform since, beyond their nature 
of contrast agent for magnetic resonance imaging due to magnetic characteristics, they 
showed echogenic properties and can be visualized using medical ultrasound.
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INTRODUCTION
Oncological hyperthermia (HT) is a therapy consisting in increasing tumor temperature between 
40°C and 45°C for about 1 hour in two to three weekly sessions often concomitantly with radiotherapy 
(RT) and sometimes radiochemotherapy (Falk and Issels, 2001; Hildebrandt et al., 2002; van der 
Zee, 2002; Wust et al., 2002).
Effectiveness is critically related to the ability of heating the tumor almost uniformly and persistently 
during the HT session. As a matter of fact, the reaching of a breakpoint temperature, conventionally 
assumed cumulatively equivalent to 43°C according to the definition of cumulative equivalent minutes 
at 43 °C (Sapareto and Dewey, 1984) for a significant fraction and over a significant volume of the 
tumor (90%), is mandatory for clinical success in most of the tumors (Dewhirst and Sim, 1984; Thrall 
et al., 2000).
External heating devices based on microwaves, radiofrequency (RF), ultrasound (US), or 
infrared are often inadequate for treating the whole tumor volume, especially deep-seated ones 
(Wust et al., 2002), and although the physiological vasodilatory-based temperature control can be in 
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principle counteracted, it would require multisite direct invasive 
temperature monitoring, which is uncomfortable, harmful, and 
possibly unethical.
Invasive temperature monitoring shows an extreme 
inhomogeneous distribution and a typical initial delay both for 
temperature rise and hyperemia (Kim et al., 1976; Gerweck, 
1977; Gerweck et al., 1979; Guiot et al., 1998).
The need for endogenous heat generation mechanisms led to 
the investigation of the so-called magnetic fluid hyperthermia 
(MFH), consisting in the in situ administration of a stable 
colloidal suspension of biocompatible superparamagnetic iron 
oxide nanoparticles (SPIONs), which can be activated by external 
magnetic fields (Hildebrandt et al., 2002). The physical bases and 
the possibility of tailoring treatments based on the fine tuning 
of a few parameters are well described in the literature (Spirou 
et al., 2018).
Clinical studies of MFH based on Food and Drug 
Administration–approved and marketed systems (MagForce® 
activated by MFH® 300F or NanoActivator®) in combination 
with RT, even in very challenging tumors such as recurrent 
glioblastoma (Maier-Hauff et al., 2007) and metastatic bone 
tumors (Matsumine et al., 2011), showed very promising results.
A number of research are still open to innovative approaches 
able to improve the biological benefits of the MFH (Ansari 
et al., 2019).
Magnetic nanobubbles (NBs) containing paclitaxel and 
decorated with herceptin and ultrasmall superparamagnetic 
iron oxide have been studied for targeted drug delivery and 
multimodal imaging in breast cancer cells (Song et al., 2017). 
Recently, pemetrexed- and pazopanib-carrying NBs with 
magnetic responsiveness and US sensitivity properties have been 
designed as new theranostic system for targeted non–small cell 
lung cancer (Şanlıer et al., 2019).
The rationale for the combination of HT and RT is based on 
some “complementary” effects, namely, the fact that tumor cells 
are more radioresistant when their microenvironment is hypoxic 
(Sapareto and Dewey, 1984) and acidic (Dewhirst and Sim, 1984) 
and, during the S phase, when the cell is more sensitive to heat 
(Thrall et al., 2000).
Other indirect effects are even more important. Due to 
the abnormal structure of the angiogenically driven tumor 
vasculature, which is irregular and leaky, heat is less effectively 
dissipated and can both damage the microvasculature and induce 
local HT (Hildebrandt et al., 2002). Therefore, improved blood 
circulation reduces hypoxia and increases environmental pH 
transitorily reversing radioresistance (and chemoresistance).
Being tumor oxygenation one of the main targets of the 
hyperthermic treatment, here we investigated the use of oxygen 
nanocarriers “decorated” with SPIONs, hereinafter named 
magnetic oxygen-loaded nanobubbles (MOLNBs), which 
combined the magnetic-based increase in temperature with a 
direct oxygenation effect in the tumor volume.
Oxygen-loaded microbubbles have been already employed 
both for sonography as US contrast agents and for oxygen 
delivery to the tumor hypoxic microenvironment (Eisenbrey 
et al., 2018; Yang et al., 2018).
Nanobubbles are spherical core-shell structure, filled with 
gas or vaporizable compounds, with sizes in the nanometer 
order of magnitude. They were designed to improve stability 
in the circulation and to allow extravasation and accumulation 
in tumor tissue by Enhanced permeability and retention (EPR) 
effect (Cavalli et al., 2016).
Previously, theranostic polymer-shelled NBs have been 
designed showing the capability to act as drug carriers and US 
imaging systems (Cavalli et al., 2015). Oxygen-loaded nanobubbles 
(OLNBs) were already manufactured, patented, and proposed by 
our research team for application to other pathologies (Cavalli 
et al., 2009; Magnetto et al., 2014; Banche et al., 2015; Prato et al., 
2015), and preliminary studies on the coupling of SPIONs with 
OLNBs were proposed as well (Zullino et al., 2015).
MATERIALS AND METHODS
Materials
Unless otherwise stated, the materials employed were purchased 
from Sigma-Aldrich (St. Louis, MO, USA). All the reagents were 
of analytical grade. Epikuron 200® was a kind gift from Cargill.
Synthesis of SPIONs
Superparamagnetic iron oxide nanoparticles (Fe3O4) were prepared 
tuning a protocol previously reported (Zhang et al., 2015).
Weighed amounts of FeCl2 4H2O (0.99 g) and FeCl3 6H2O 
(2.703 g) were added to deionized distilled water (50 mL) under 
continuous nitrogen purging and stirred at 85°C until dissolved. 
Then, standardized ammonium hydroxide solution (14 mL) was 
dropwise added, followed by stirring at 85°C for 1 h. After the 
system reached a precipitation state, it was allowed for cooling 
and settling of the precipitation in the bottom of the flask. After 
precipitation, the supernatant liquid is first decanted carefully 
without disturbing precipitation. The precipitate was washed 
with water, and then it was allowed to expose in air for 24 h.
The obtained SPION nanoparticles were stored at 4°C, until 
the MOLNB preparation. Then they were added to the preformed 
NB nanosuspension, exploiting the electrostatic interaction with 
the dextran sulfate shell.
Preparation of MOLNB formulations
An ethanolic solution of Epikuron 200® (1% wt/wt) and palmitic 
acid as cosurfactant (1% wt/wt) was added under stirring to 
perfluoropentane (PFP, C5F12) at room temperature. Then, a 
volume of ultrapure water was slowly added to the mixture under 
mild stirring until the formation of an emulsion. The system was 
then homogenized for 3  min using a high-shear homogenizer 
(Ultraturrax, IKA, Germany) in an ice bath. The nanosuspension 
was saturated with O2 until reaching a 35 mg/L concentration 
in the aqueous medium. Then, an aqueous solution of dextran 
sulfate sodium salt (1% wt/wt) was added drop-wise to form the 
NB polymeric shell under an oxygen purge. Finally, 1 or 2 mg/mL 
of SPIONs was added drop-wise to the suspension under mild 
stirring at room temperature (Figure 1).
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For the preparation of fluorescent NBs, 6-coumarin was 
loaded into the NB core by addition of the fluorochrome directly 
to PFP solution. The same preparation protocol used for blank 
formulations was employed. As control, blank dextran-shelled 
OLNBs were also prepared, without the addition of SPIONs.
Physicochemical Characterization of NB 
Formulations
Average hydrodynamic diameter, polydispersity index, and 
zeta-potential values of the NB formulations and SPIONs 
were determined by photocorrelation spectroscopy using a 
laser light scattering at a temperature of 25°C and a scattering 
angle of 90°. The samples were diluted with filtered water 
(1:30 dilution). Each measured value was the average of 10 
readouts. For zeta-potential determination, samples of the 
NB formulations were placed in the electrophoretic cell of the 
same instrument. The electric field was set to 14 V/cm. The 
viscosity of the NB formulation was determined at 25°C using 
a Ubbelohde capillary viscosimeter (Schott Gerate, Mainz, 
Germany). The osmolarity was determined at 25°C using a 
Knauer osmometer.
The morphology of blank OLNB, MOLNB, and SPIONs 
was observed by transmission electron microscopy (TEM) 
in conventional and high-resolution (HR) modes, by using a 
JEOL2200FS microscope working at 200 keV. The diluted NB 
aqueous suspensions were sprayed on Formwar-coated copper 
grid and air dried before observation.
Determination of NB Physical Stability 
Over Time
The physical stability of blank OLNB and MOLNB was evaluated 
over time. The average diameter and morphology of the NB 
formulations stored at 4°C were determined up to 2 months.
Ultrasound Imaging Evaluation
B-mode US imaging was carried out to investigate the 
echogenicity of the OLNBs and the MOLNBs. Nanobubble 
aqueous suspension at concentration ~1  ×  1010 NBs/mL was 
pipetted in a tank containing demineralized water and gently 
mixed using a magnetic stirrer in order to have a homogeneous 
suspension. At the bottom of the tank, an acoustic absorbing pad 
was placed to minimize acoustic reflections. The experiment was 
performed at increasing temperatures: 25°C, 37°C, and 41°C with 
the aim to mimic the room temperature and the physiological 
and hyperthermic conditions. Nanobubbles were insonified by 
a US clinical echomachine (MyLab™ 25Gold; Esaote, Genova, 
Italy), equipped with a linear array transducer (LA523, 7.5 
MHz central frequency; Esaote) operating in B-mode using 
the small parts imaging preset. A sketch of the experimental 
setup is shown in Figure 2. B-mode cineloops were acquired 
at increasing Mechanical Index (MI), i.e., increasing acoustic 
power, maintaining the same imaging preset. B-mode cineloops 
of demineralized water in the absence of NBs were also acquired 
as reference.
Hyperthermic and Magnetic 
Measurements
Hyperthermia properties were evaluated by calorimetric 
measurements by means of an AC commercial applicator 
(nanoScale Biomagnetics DM100, Zaragoza, Spain).
Magnetic oxygen-loaded nanobubbles decorated with SPIONs 
at a concentration of 1 or 2 mg/mL were exposed for 10 min to an 
RF alternating magnetic field of amplitude = 250 Oe, frequency = 
429 kHz. The temperature increase was measured with an optical 
fiber thermometer to avoid the coupling with the RF field.
Isothermal magnetization curves at room temperature were 
measured by an alternating gradient force magnetometer.
FIGURE 1 | Sketch of MOLNB structure [dextran NBs covered by Fe3O4 nanoparticles (not to scale)].
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In Vitro Oxygen Release Studies
In vitro oxygen release from MOLNBs and in the absence of 
SPIONs was investigated using the dialysis bag technique. The 
donor phase, consisting of 3 mL of MOLNBs or OLNBs, was 
placed in a dialysis bag (cellulose membrane, 12 kDa) Then, it 
was put in 45 mL of saline solution (NaCl 0.9% wt/vol) whose 
oxygen concentration was previously reduced (up to 1 mg/L) 
with a N2 purge in order to mimic hypoxic conditions. The 
concentration of oxygen released by diffusion from MOLNBs 
into the receiving phase was monitored for 24 h, using an 
oximeter (HQ40d model; Hach).
The in vitro oxygen release kinetics was evaluated at different 
temperatures (i.e., 25°C, 37°C, and 41°C) to simulate ambient 
and normal body temperatures and hyperthermic sessions, 
respectively.
Oxygen release measurements under the effect of the magnetic 
field were prevented by the metallic nature of the oximetry probe 
and its interference with the AC applicator.
Cell Internalization
TUBO cells, a cloned rat Her2/neu+ cell line established from 
a lobular carcinoma of a BALB-neuT mouse, were cultured in 
high-glucose Dulbecco’s modified eagle medium (DMEM), 
containing 20% fetal bovine serum, 2 mM l-glutamine and 1% 
penicillin-streptomycin in a humidified CO2/air incubator at 
37°C. For NB uptake evaluation, TUBO cells were plated in 6-well 
plates on glass coverslips and incubated in DMEM medium for 
24  h with/without 10% vol/vol 6-coumarin–labeled NBs in a 
humidified CO2/air incubator at 37°C. After 24-h incubation 
with 6-coumarin–labeled NBs, TUBO cells were fixed, stained 
with 4′,6-diamidino-2-phenylindole (DAPI) to visualize cells 
nuclei, and then visualized by microscope. Fluorescence images 
were acquired by an LSM710 inverted confocal laser scanning 
microscope (Carl Zeiss, Oberkochen, Germany) equipped with 
a Plan-Neofluar 63 × 1.4 oil objective, which allowed a field view 
of at least five cells. Wavelength of 488 nm was used to detect 
fluorescent OLNBs and of 460 nm to detect the labeled nuclei. 
The acquisition time was 400 ms.
Statistical Analysis
Data are expressed as means ± SD. Significance between 
experimental groups was determined by one-way analysis of 
variance followed by the Bonferroni multiple-comparisons 
posttest using GraphPad InStat software (San Diego, CA, USA). 
p ≤ 0.05 was considered significant.
RESULTS
Physicochemical Characterization of NB 
Formulations
Decorated SPIONs and oxygen-loaded NBs were manufactured 
using biocompatible components, tuning the preparation protocol, 
which was previously reported (Argenziano et al., 2017).
The physicochemical parameters of OLNBs before and after 
the addition of SPIONs are reported in Table 1.
The zeta-potential of SPIONs was +11.63 mV. The positive 
charge is suitable for obtaining a binding on the negative polymer 
shell by electrostatic interactions. The presence of SPIONs on the 
polymer shell produced a decrease of the MOLNB zeta potential 
of about 30%. This behavior can be related to the electrostatic 
binding of SPIONs and the partial shielding of the surface charge 
of NBs.
The pH of the NB nanosuspension was 5.86, the viscosity was 
about 1.42 cP, and the osmolarity was 354 mOsm, values suitable 
for future clinical translation. These parameters were not affected 
by the presence of the SPIONs. Moreover, the nanosuspension 
was homogeneous and stable over 2 months.
Figure 3 shows the TEM images of both SPIONs (Figure 3A) 
and blank dextran-shelled OLNBs (Figures 3B, C). The spherical 
and hollow morphology of the NBs is clearly visible in the images.
The TEM studies of functionalized nanobubbles (MOLNBs) 
revealed a more contrasted shell with respect to OLNBs, 
maintaining the classic spherical shape, as shown in Figure 4A. 
By progressively increasing the magnification, the “granular” 
structure of the SPIONs in the shell becomes evident 
(Figures  4B,  C). An average diameter of about 390 nm was 
confirmed for MOLNBs.
Fluorescent OLNBs were visible under fluorescence microscope 
and the morphology and physicochemical properties were the 
same as previously described.
FIGURE 2 | Experimental setup used for US imaging.






Zeta Potential ± 
SD (mV)
Blank OLNBs 375.5 ± 20.4 0.21 ± 0.01 −30.4 ± 3.45
Fluorescent OLNBs 378.2 ± 26.3 0.21 ± 0.01 −28.8 ± 3.68
MOLNBs 385.4 ± 25.8 0.19 ± 0.02 −19.72 ± 1.24
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In vitro stability studies showed that the nanosuspension was 
homogeneous and stable over 2 months.
Ultrasound Imaging Evaluation
Ultrasound experiments revealed that MOLNBs showed an 
increased echogenicity with respect to OLNBs (Figure 5). 
The ability of both the OLNBs and MOLNBs to generate 
an echogenic response was enhanced at 37°C, as visually 
demonstrated. The insonation affected the detectability 
increasing the volume size of NBs favoring the vaporization, 
due to acoustic droplet vaporization (ADV) phenomenon 
(Kripfgans et al., 2004). A decrease in the echogenicity was 
observed at 41°C, probably because most of the NBs showed a 
different vaporization behavior. We could speculate that this 
could be related to the phase transition of phospholipids (i.e., 
phosphatidylcholine) present in OLNBs from the gel to the 
liquid crystalline state. This effect was previously observed 
also for Sonovue® (Bracco, Italy), a commercial US contrast 
agent consisting of microbubbles loaded with SF6 and coated 
with a phospholipidic shell (Guiot et al., 2006).
Hyperthermic and Magnetic 
Measurements
A first simulation of the hyperthermic session was performed 
by exposing for 10 min a colloidal suspension of MOLNBs to 
an RF magnetic field. A temperature increase of the sample was 
observed during the RF field application. In Figure 6, the time 
dependence of the suspension temperature under irradiation is 
reported for two different NB concentrations. After 10 min of 
exposure, a temperature increase of 5°C (at field amplitude of 250 
Oe) or 7°C (at field amplitude of 300 Oe) for the 2 mg/mL SPION 
concentration was attained.
The specific heat absorption rate (SAR), expressed in W/g, 
was evaluated by using the following expression (Eq. 1):
 






where c is the specific heat capacity of the sample (for diluted 
solutions as in the present case, c is equal to the heat capacity 
of the solvent, assumed to be 4.18 J/g °C), ρ is the density of the 
FIGURE 3 | (A) HRTEM image of SPIONs; (B, C) TEM images of blank-shelled OLNBs at different magnifications.
FIGURE 4 | (A) TEM image of an MOLNB; (B) HRTEM image of the square region in (A); (C) HRTEM image of the square region in (A) showing the (311) lattice 
planes of a Fe3O4 nanoparticle.
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solvent (equal to 1 g/mL), C is the concentration of the magnetic 
NB in the solvent (2 g/L), and dT/dt is the heating rate of the 
sample. The heating rate was calculated by fitting the temperature 
increase ΔT with a linear trend at early times, i.e., first 10 seconds 
of the experiment.
Depending on the field amplitude, the SAR values range 
between 37.7 and 46.1 W/g.
The deviation from the linearity at longer times of the temperature 
increase is dictated by the combined effects of heating power and 
thermal losses. The temperature increase of the solution can be 
attributed to the magnetic properties of MOLNBs, as confirmed by 
room temperature isothermal magnetization measurements.
In Figure 7, hysteresis loop measurements are reported, 
confirming the superparamagnetic behavior of magnetic NBs, 
characterized by no remanence and no hysteresis.
In Vitro Oxygen Release
The release studies showed the capability of OLNBs and MOLNBs 
to store and release oxygen. The in vitro oxygen release kinetics 
from MOLNBs into a hypoxic receiving phase showed a biphasic 
profile (Figure 8). In the first 4 h, oxygen was rapidly released 
from MOLNBs, reaching an oxygen concentration between 
about 4 and 6 mg/L at 25°C and 41°C, respectively. Subsequently, 
an almost constant and slow oxygen release was obtained. After 
FIGURE 5 | Snapshots of the B-mode cineloops of control experiment (demineralized water only), OLNBs, and MOLNBs at MI = 1.1 (i.e., maximum acoustic power) 
and different temperatures. Red arrows indicate the focus of the US probe.
FIGURE 6 | Variation of temperature as a function of time under exposure of RF magnetic field for two different AC field amplitudes.
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24 h, the oxygen concentration in the external receiving phase 
kept constant, because an equilibrium between the internal and 
external phases was reached. A temperature-dependent release 
profile was observed. The presence of SPIONs on NB shell did 
not affect the oxygen release capability. Indeed, the same in vitro 
release profiles were obtained for OLNBs at all the temperatures.
Cell Internalization
Fluorescence microscopy was used to verify if NBs were 
internalized by breast cancer in vitro model. Results show that 
NBs were avidly internalized by TUBO cells and were localized 
only in cellular cytoplasm compartment (Figure 9). This result 
indicates that MOLNBs were able to deliver a gas or a drug 
directly inside the cancer cells.
DISCUSSION
Drug-loaded NBs have been previously studied, showing an 
increase in drug blood lifetime, extravasation capability, and 
FIGURE 7 | RT magnetization curve for MOLNBs.
FIGURE 8 | In vitro oxygen release from MOLNBs at different temperatures (i.e., 25°C, 37°C, and 41°C).
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accumulation in tumors by passive targeting, exploiting the 
EPR effect, in comparison with microbubble (Cavalli et al., 
2016). Oxygen-loaded nanobubbles have been developed to 
store and deliver oxygen in hypoxic tissues. Oxygen-loaded 
nanobubbles are also very attractive nanocarriers for their 
potential application in cancer therapy, due to their theranostic 
property. Moreover, they could play a key role as radiosensitizer 
in RT, where the enhancing effect of the oxygen is well known. 
In the literature, magnetic oxygen-loaded microbubbles were 
previously described for dual-modality treatment of tumor 
hypoxia, showing enhanced antitumor effects (Huang et al., 
2015; Sheng et al., 2017). Here, the functionalization of OLNBs 
surface with SPIONs to obtain MOLNBs is reported. This new 
specific nanoscaled carrier demonstrated to be effective as locally 
hyperthermic agent in in vitro studies.
Magnetic oxygen-loaded nanobubbles have a well-defined 
hollow structure, whose shell is densely decorated by SPIONs, 
as shown by TEM analysis. The electrostatic binding between 
the SPION positive charge and the negative surface charge of 
dextran sulfate–shelled NBs is strong enough to produce a 
stable nanostructure.
The preliminary hyperthermic investigations of this work 
confirmed that MOLNBs might be a promising new theranostic 
MFH agent, presenting the additional advantages of delivering 
oxygen to cancer cells and allowing their imaging detection.
Interestingly, under RF magnetic field, MOLNBs 
manufactured with an SPION concentration of 2 mg/mL 
produced a temperature increase as large as 5°C at field 
amplitude of 250 Oe and 7°C at 300 Oe, after 10 minutes 
of treatment. The calculated SAR values of MOLNBs 
demonstrated a good heating efficiency and were comparable 
with those recently obtained by Umut et al. (2019), Arosio et 
al. (2019), and Sudame et al. (2019).
The magnetic and hyperthermic properties can be possibly 
related to the small dimensions of the SPIONs and the average 
number of SPIONs that decorated the OLNB shell. As a matter of 
fact, preliminary investigations by Albertini et al. showed that the 
thermic effect can be related to the presence of SPION clusters, 
reaching higher temperatures in the presence of increased 
SPION agglomeration (personal communication). Therefore, 
based on these results, MOLNBs could represent an innovative 
multitheranostic approach for hyperthermic treatment.
In addition, a significant and sustained in vitro oxygen delivery 
from MOLNBs was detected in vitro. Importantly, the presence 
of SPIONs on NB shell did not affect the oxygen release kinetics 
in comparison with OLNBs.
Oxygen release from NBs is due to passive gas diffusion across 
the shell and is mainly controlled by the difference in the gas 
concentration between the core and the external environment. 
Interestingly, MOLNB core, being composed by PFP in which 
oxygen has a very high solubility, can act as a gas reservoir from 
which oxygen can be slowly released with kinetics depending 
on its partial pressure, according to Henry law. Moreover, it is 
necessary to take into account for the oxygen release kinetics the 
high internal NB pressure that is inversely correlated with the 
bubble radius, according to the Laplace law.
Furthermore, the oxygen delivery from MOLNBs could 
be tuned for specific hyperthermic treatment by modulating 
the nanostructure of the nanocarriers, i.e., shell thickness and 
particle diameter.
According to Figure 8, the temperature increase in the 
hyperthermic range is responsible for a sustained enhancement 
of oxygen release over time, which determines an oxygen 
concentration increase of about 0.5 mg/L in the external 
aqueous solution. Such effect is possibly related to modifications 
in shell permeability, associated to changes of the MOLNB 
FIGURE 9 | OLNB internalization by TUBO cell line. Cell nuclei after DAPI staining (in blue; OLNBs, in green). Magnification ×63.
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nanostructure. Indeed, phospholipids underwent sol-gel-sol 
transition in function of the temperature. The long-lasting 
oxygen release over time might be expected in heated biological 
tissues and would contribute to their oxygenation in addition 
to the physiological mechanisms related to the heat-induced 
hyperemia.
Unfortunately, we were unable to directly record the oxygen 
delivery in the presence of a magnetic field. Indeed, direct 
measurements were prevented when MOLNBs were in such 
conditions, due to the metallic composition of the oximetry 
probe. In our experimental setup, the oxygen concentration 
was measured just after the withdrawal of the sample from 
the magnetic field. We observed that the sustained in vitro 
oxygen release profile was maintained also after irradiation. 
This might indicate the integrity of the NB structure. The 
occurrence of mechanical modifications of the MOLNB 
shell following the interaction with RF magnetic field could 
be excluded, because no massive oxygen delivery after the 
hyperthermic session was observed.
The theranostic nature of the MOLNBs was confirmed by 
preliminary US imaging, showing the system echogenicity. For 
both OLNBs and MOLNBs, the acoustic contrast resulting from 
B-mode imaging increased when the temperature increased from 
room to body temperature. The echogenicity of NB is related to 
droplet-to-bubble phase transition.
Indeed, PFP-loaded NBs present the ability to be activated by 
US, by means of a phenomenon called ADV. Acoustic droplet 
vaporization allows nanodroplets to be converted into bubbles 
following a US pulse, inducing the liquid-to-gas transition within 
the bubble core (Kripfgans et al., 2004). However, the MOLNBs 
revealed an enhanced acoustic contrast with respect to OLNBs, 
probably depending on the difference in compressibility and 
density with respect to water.
Finally, in vitro biological studies confirmed that MOLNBs 
can be easily internalized by tumor cells, and no cytotoxic effects 
were observed.
CONCLUSIONS
We prepared and characterized superparamagnetic theranostic 
OLNBs with echogenicity, heating potential, and internalization 
capability in a cancer cellular model. Magnetic oxygen-loaded 
nanobubbles may be a new interesting nanotool for multifaced 
tumor treatment, both inducing HT upon RF magnetic field 
exposure and releasing oxygen as radiosensitizer for RT. This 
nanoformulation might provide a new approach to improve the 
therapeutic cancer outcomes, allowing to locally kill cancer cells 
by heating the tumor tissues at hyperthermic temperatures.
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